GENOVESE, Filippo
 Distribuzione geografica
Continente #
NA - Nord America 4.595
EU - Europa 3.893
AS - Asia 2.690
SA - Sud America 412
Continente sconosciuto - Info sul continente non disponibili 93
AF - Africa 58
OC - Oceania 5
Totale 11.746
Nazione #
US - Stati Uniti d'America 4.484
GB - Regno Unito 1.390
IT - Italia 1.041
SG - Singapore 786
CN - Cina 668
DE - Germania 338
BR - Brasile 322
VN - Vietnam 317
HK - Hong Kong 298
SE - Svezia 240
FR - Francia 169
BD - Bangladesh 137
RU - Federazione Russa 129
FI - Finlandia 113
PL - Polonia 105
KR - Corea 89
UA - Ucraina 80
IN - India 71
TR - Turchia 67
CA - Canada 61
JP - Giappone 60
ID - Indonesia 44
NL - Olanda 44
BE - Belgio 32
BG - Bulgaria 32
AR - Argentina 31
CH - Svizzera 30
IE - Irlanda 27
IQ - Iraq 27
MX - Messico 27
PK - Pakistan 22
ES - Italia 21
LT - Lituania 21
ZA - Sudafrica 19
AT - Austria 18
AE - Emirati Arabi Uniti 12
UZ - Uzbekistan 12
CO - Colombia 11
CZ - Repubblica Ceca 11
DK - Danimarca 11
MY - Malesia 11
PY - Paraguay 11
EC - Ecuador 10
VE - Venezuela 10
JO - Giordania 9
MA - Marocco 8
CL - Cile 7
LI - Liechtenstein 6
PE - Perù 6
PH - Filippine 6
SA - Arabia Saudita 6
CR - Costa Rica 5
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
IR - Iran 5
JM - Giamaica 5
PS - Palestinian Territory 5
TW - Taiwan 5
AU - Australia 4
AZ - Azerbaigian 4
BH - Bahrain 4
GR - Grecia 4
GT - Guatemala 4
KE - Kenya 4
KZ - Kazakistan 4
NO - Norvegia 4
PT - Portogallo 4
TZ - Tanzania 4
AL - Albania 3
BY - Bielorussia 3
ET - Etiopia 3
NG - Nigeria 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
NP - Nepal 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BS - Bahamas 1
CG - Congo 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
Totale 11.644
Città #
Southend 1.170
Ashburn 500
Santa Clara 489
Singapore 466
Chandler 293
Hong Kong 288
Fairfield 261
San Jose 241
Woodbridge 219
Hefei 202
Ann Arbor 185
Houston 165
Nyköping 138
Dearborn 135
Jacksonville 125
Frankfurt am Main 119
Wilmington 112
Beijing 109
Modena 107
Cambridge 105
London 98
Seattle 95
Council Bluffs 90
Los Angeles 88
Ho Chi Minh City 87
New York 87
Kraków 77
Hanoi 76
Seoul 75
The Dalles 73
Helsinki 68
Milan 64
Tokyo 57
Shanghai 41
Munich 38
Orem 35
Bologna 34
Buffalo 34
Lauterbourg 32
Moscow 32
Princeton 32
Sofia 32
Chicago 31
Fremont 31
Jakarta 31
Rome 29
San Diego 29
Eugene 26
Izmir 26
Boardman 24
Dublin 24
Da Nang 22
Porto Alegre 21
São Paulo 21
Warsaw 21
Brussels 20
Dallas 20
Redwood City 19
Lahore 17
Padova 17
Parma 17
Atlanta 15
Phoenix 15
Turku 15
San Gimignano 14
Nuremberg 13
Rio de Janeiro 13
Stockholm 13
Bremen 12
Montreal 12
Paris 12
Reggio Emilia 12
Toronto 12
Amsterdam 11
Des Moines 11
Ferrara 11
Johannesburg 11
Naples 11
Ravenna 11
Zurich 11
Brno 10
Brooklyn 10
Chennai 10
Vienna 10
Columbus 9
Denver 9
Guangzhou 9
Haiphong 9
Mumbai 9
Prato 9
Tashkent 9
Amman 8
Charleston 8
Jinan 8
Kent 8
Ottawa 8
Salt Lake City 8
Verona 8
Vicenza 8
Belo Horizonte 7
Totale 7.629
Nome #
Oxytetracycline-Protein Complex: The Dark Side of Pet Food 775
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 464
Enamel peptides reveal the sex of the Late Antique ‘Lovers of Modena’ 453
Metodo per la funzionalizzazione sito specifica di molecole proteiche 433
An autoregulatory loop controls the expression of the transcription factor NF-Y 428
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 414
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 401
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 398
Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides 371
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 366
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 365
Allosteric Inhibition of human Thymidylate Synthase. 359
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer 349
A proteomic approach to investigate the mechanism of action of anticancer peptides 343
Proteomic Approach to the Detection of the Mechanism of Action of Anticancer Peptides 342
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 332
Design, synthesis and biological evaluation of non-covalent AmpC Beta-Lactamases inhibitors 294
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 293
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 290
Chairperson EUTROC- Mayo Conference-Berlin - Preliminary characterization of pharmacodynamic biomarkers for LR-peptide growth inhibition of ovarian cancer (OC) cell models. 287
Invited lecture to 18th World Congress on Advances in Oncology and 16th International Symposium on Molecular Medicine 10-12 October, 2013, Creta Maris, Hersonissos, Crete, Greece 283
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 280
MALDI-TOF MS as a tool for rapid Identification of Low Protein Affinity Drug Fragments. 271
Discovery and preliminary characterization of a novel inhibitor of the SOS response in Pseudomonas aeruginosa 268
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 261
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 247
EVALUATION OF LR STABILITY BY LC CHIP Q-TOF AND QUANTITATIVE DETERMINATION OF LR PEPTIDE CELL PENETRATION BY LC-MS/MS 244
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 243
LC-MS/MS Helps Characterizing THP-1 Cells Proteome After Infection with Drug Resistant Leishmania Strains 233
Merging disulphide bonds for drug design Interfering with a cancer key protein 227
A dual-Omics approach to identify the modulated proteins/genes in THP-1 cells infected with different drug resistant L. infantum clinical isolates. 226
Development and validation of a new storage procedure to extend the in-use stability of azacitidine in pharmaceutical formulations 206
Label-Free Mass Spectrometry Proteomics Reveals Different Pathways Modulated in THP-1 Cells Infected with Therapeutic Failure and Drug Resistance Leishmania infantum Clinical Isolates 181
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 173
Insights into host-target interaction from the proteome modulation analysis through untargeted LC-MS/MS Proteomics of drug resistant L infantum-THP1 infected cells 171
LC-MS/MS proteomics for the rapid and selective screening of drug resistances in Leishmania infantum clinical isolates 167
Deciphering Host–Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance 165
Quantitative comparison of the protein corona of nanoparticles with different matrices 143
Totale 11.746
Categoria #
all - tutte 37.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022681 39 82 41 43 27 48 56 38 60 40 120 87
2022/2023920 95 121 60 91 81 122 43 120 71 13 56 47
2023/2024937 33 39 44 73 232 74 156 88 23 26 59 90
2024/20252.103 80 29 75 160 386 281 183 128 196 83 223 279
2025/20263.517 243 145 227 377 554 247 475 192 297 345 242 173
2026/202771 71 0 0 0 0 0 0 0 0 0 0 0
Totale 11.746